News – Page 865 – Endpoints News

Three Biogen staffers test positive for coronavirus in wake of Boston hotel meeting

6 years ago

More than half of its gross sales ultimately went to payers as rebates, Sanofi says

6 years ago

Nobody but Deerfield wants Melinta; Novartis finds a new drug discovery partner

6 years ago

MacroGenics loses CMO Jon Wigginton as commercialization looms

6 years ago

After a trendsetting role in global biotech venture investing, David Mott parts ways with NEA

6 years ago

FDA requires boxed warning for Singulair and its generics

6 years ago

GSK's Emma Walmsley awarded £8.4M pay package after £2.5M rise, finally catching up with fellow pharma CEOs

6 years ago

How do depressed rats respond to psychedelics? New data offer insight into the human experience

6 years ago

Fred Hutchinson Center initiates mandatory work-from-home policy as outbreak roils businesses, conferences

6 years ago

'Dramatic times': How did an $8B surge in NIH grants over five years change research on the ground (if at all)?

6 years ago

Vilified for high drug prices, what does the profitability of major US pharma companies look like?

6 years ago

Tackling inherited blindness, Editas and Allergan use CRISPR for the first time in the human body

6 years ago

Bristol-Myers joins forces with digital therapeutics co; Wearable cardioverter defibrillator scores $145M+ in Series ...

6 years ago

Can reformulation of an AstraZeneca castoff rival Takeda's new heartburn drug? Here's a $26M bet on yes

6 years ago

AMAG CMO hits the exit just as biotech searches for new CEO to right a ship rocked by Makena controversy

6 years ago

AbbVie and Allergan finally set (rough) date for wedding as one parent agrees to the match

6 years ago

Individualized therapies: CBER director discusses challenges, regulatory approach

6 years ago

New study suggests it costs $1.3B in R&D investment to bring a drug to market. How did it get there?

6 years ago

Amunix grabs $73M from Frazier, Omega to fuel shift to T cell engagers

6 years ago

Add Takeda and Alnylam to the menu of global drugmakers looking to stymie the coronavirus epidemic

6 years ago

As costs continue to soar ever higher, AstraZeneca sees new HQ sticker price gyrate to $1.28B

6 years ago

Hear hear! Ear gene therapy player Akouos draws $105M in fresh capital

6 years ago

Boasting new discoveries from Xtandi, Erleada inventors, ORIC pitches $86M IPO on cancer drugs targeted at resistance

6 years ago

$7.5B in emergency congressional coronavirus prep; Sickle cell biotech sets terms for IPO

6 years ago

First page Previous page 862 863 864865866 867 868 Next page Last page